Suppr超能文献

炎症性肠病的营养考虑。

Nutrition Considerations in Inflammatory Bowel Disease.

机构信息

Department of Internal Medicine, University of Chicago Medicine, Chicago, Illinois, USA.

Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, Illinois, USA.

出版信息

Nutr Clin Pract. 2021 Apr;36(2):298-311. doi: 10.1002/ncp.10628. Epub 2021 Mar 2.

Abstract

The purpose of this article is to provide an updated review of the definition, prevalence, causes, and clinical management of malnutrition in inflammatory bowel disease (IBD). Prevalence of malnutrition in IBD is estimated to be between 6.1% and 69.7% depending on the definition used, the type of IBD, the clinical setting, and whether the IBD is active or in remission. Whereas older definitions of malnutrition have been found to be correlated with mortality and length of hospital stay, the more recent European Society for Clinical Nutrition and Metabolism (ESPEN) 2015 and the Global Leadership Initiative on Malnutrition (GLIM) definitions provide significantly different prevalence estimates of malnutrition when applied to the same patient population, and further work is needed to validate these two definitions against clinical outcomes. In patients with IBD with identified malnutrition, oral nutrition supplementation, enteral nutrition, or parenteral nutrition should be started. In malnourished patients with Crohn's disease undergoing surgery, preoperative enteral nutrition has been demonstrated to reduce the rate of postoperative complications. Overall, patients with IBD are at significant risk for malnutrition and should be screened for malnutrition by using a validated screening tool. The management of malnutrition in IBD is complex, and studies are often limited in their size or their ability to demonstrate an improvement in clinical outcomes based on specific nutrition-related interventions. Future studies particularly regarding the validation of new screening tools and perioperative management of malnutrition may provide insight into the standardization of diagnosis and management of malnutrition in IBD.

摘要

本文旨在对炎症性肠病(IBD)中营养不良的定义、流行率、病因和临床管理进行更新综述。根据所使用的定义、IBD 的类型、临床环境以及 IBD 是否处于活动期或缓解期,IBD 中营养不良的流行率估计在 6.1%至 69.7%之间。虽然较旧的营养不良定义与死亡率和住院时间长短相关,但最近的欧洲临床营养与代谢学会(ESPEN)2015 年和全球营养不良领导倡议(GLIM)定义在应用于同一患者人群时提供了截然不同的营养不良流行率估计值,需要进一步的工作来验证这两个定义与临床结果的相关性。对于已确定营养不良的 IBD 患者,应开始口服营养补充、肠内营养或肠外营养。对于接受手术的营养不良克罗恩病患者,术前肠内营养已被证明可降低术后并发症的发生率。总体而言,IBD 患者存在严重的营养不良风险,应使用经过验证的筛查工具对其进行营养不良筛查。IBD 中营养不良的管理很复杂,研究通常在规模或其基于特定营养相关干预措施改善临床结果的能力方面存在局限性。未来的研究,特别是关于新筛查工具的验证和围手术期营养不良管理的研究,可能会为 IBD 中营养不良的诊断和管理的标准化提供深入了解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验